PanGenomic Health (XCNQ:NARA) Total Stockholders Equity : C$-1.65 Mil (As of Sep. 2024)

View and export this data going back to 2022. Start your Free Trial

What is PanGenomic Health Total Stockholders Equity?

PanGenomic Health's Total Stockholders Equity for the quarter that ended in Sep. 2024 was C$-1.65 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. PanGenomic Health's Book Value per Share for the quarter that ended in Sep. 2024 was C$-0.26. The ratio of a company's debt over equity can be used to measure how leveraged this company is. PanGenomic Health's Debt-to-Equity for the quarter that ended in Sep. 2024 was 0.00.

PanGenomic Health Total Stockholders Equity Historical Data

The historical data trend for PanGenomic Health's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PanGenomic Health Total Stockholders Equity Chart

PanGenomic Health Annual Data

Trend

Dec21

Dec22

Dec23

Total Stockholders Equity

2.24

-0.22

-2.15

PanGenomic Health Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Total Stockholders Equity	Get a 7-Day Free Trial									-1.83	-2.15	-2.32	-1.48	-1.65

PanGenomic Health (XCNQ:NARA) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

PanGenomic Health's Book Value per Share for the quarter that ended in Sep. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(-1.645	-	0)	/	6.400
	=	-0.26

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

PanGenomic Health's Debt-to-Equity for the quarter that ended in Sep. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0	+	0)	/	-1.645
	=	0.00

PanGenomic Health Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of PanGenomic Health's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

PanGenomic Health Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » PanGenomic Health Inc (XCNQ:NARA) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

LL3:Germany

Address

3800 Wesbrook Mall, Suite 102, Vancouver, BC, CAN, V6S 2L9

Website

https://www.pangenomic.com

PanGenomic Health Inc is a precision health company that has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments to support mental health. The company's mobile app, the Nara App, provides consumers with a knowledge base tailored to an individual's user profile, developed by tracking a user's treatment regimen and their specific genomic, proteomics, and microbiome data. The Company's mission is to promote and improve the health and wellness of people and society by providing a technology platform that identifies plant-based solutions tailored to the health profile of each individual.

Executives

Vincent Lum	Director, Director or Senior Officer of Insider or Subsidiary (other than in 4,5,6), Senior Officer
Kaidong Zhang	Senior Officer

PanGenomic Health Headlines

No Headlines